Resolution of Partial Cataplexy in Multiple Sclerosis by Treatment with Weak Electromagnetic Fields

References

• Aldrich M. S. Narcolepsy. Neurology 1992; 42: 34–43, (suppl 6)
   PubMed Web of Science ®Google Scholar
• Aldrich M. S. The neurobiology of narcolepsy-cataplexy. Progress in Neurobiology 1993; 41: 533–541
   PubMed Web of Science ®Google Scholar
• Amatruda T. T., Black I. I. I., McKenna D. A., McCarly R. W., Hobson J. A. Sleep cycle control and cholinergic mechanisms: differential effect of carbachol injections at pontine brainstem sites. Brain Research 1975; 95: 501–515
   Google Scholar
• Anderson M., Salmon M. V. Symptomatic cataplexy. Journal of Neurology Neurosurgery and Psychiatry 1977; 40: 186–191
   PubMed Web of Science ®Google Scholar
• Babcock D. A., Narver E. L., Dement W. C., Mitler M. M. Effects of imipramine, chlorimipramine, and fluoxetine on cataplexy in dogs. Pharmacology Biochemistry and Behavior 1976; 5: 599–602
   PubMed Web of Science ®Google Scholar
• Backeland F. Effects of the day's events on sleep. Sleep and dreaming, E. Hartmann. Little Brown and Co, Boston 1970; 49–58
   Google Scholar
• Baker T. L. Introduction to sleep and sleep disorders. Medical Clinics of North America. 1985; 69: 1123–1152
   PubMed Web of Science ®Google Scholar
• Barinaga M. How scary things get that way. Science 1992; 258: 887–888
   PubMed Web of Science ®Google Scholar
• Berg O., Hanley J. Narcolepsy in two cases of multiple sclerosis. Acta Neurologica Scandinavica 1963; 39: 252–257
   PubMed Web of Science ®Google Scholar
• Billiard M., Cadilhac J. La narcolepsie. Revue Neurologique 1981; 141: 515–527
   Google Scholar
• Claveria L. E., Curzon G., Harrison M. J. G., Kantamaneni B. D. Amine metabolites in the cerebrospinal fluid of patients with disseminated sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1974; 37: 715–718
   PubMed Web of Science ®Google Scholar
• Coleman R. M., Pollak C. P., Weizman E. D. Periodic movements in sleep (nocturnal myoclonus): relation to sleep disorders. Annals of Neurology 1980; 8: 416–421
   PubMed Web of Science ®Google Scholar
• Dafny N. Electrophysiological evidence of photic, acoustic, and central input to the pineal body and hypothalamus. Experimental Neurology 1977; 55: 449–457
   PubMed Web of Science ®Google Scholar
• Dafny N. Two photic pathways contribute to pineal evoked responses. Life Sciences 1980; 26: 737–742
   PubMed Web of Science ®Google Scholar
• Davidson D., Pullar I. A., Mawdsley C., Kinloch N., Yates M. Monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Journal of Neurology, Neurosurgery and Psychiatry 1977; 40: 741–745
   PubMed Web of Science ®Google Scholar
• Drake F. R. Narcolepsy: brief review and report of cases. American Journal of Medical Science 1949; 218: 101–114
   PubMed Web of Science ®Google Scholar
• Ekbom K. Familial multiple sclerosis associated with narcolepsy. Archives of Neurology 1966; 15: 337–344
   PubMedGoogle Scholar
• Ekbom K., Westerberg C. E., Osterman P. O. Focal sensory motor seizures of spinal origin. Lancet 1968; 1: 67
   PubMed Web of Science ®Google Scholar
• Eleftheriou B. E. The neurobiology of the amygdala. Plenum Press, New York 1972; 11–18
   Google Scholar
• Espir M. L. E., Millac P. Treatment of paroxysmal disorders in multiple sclerosis with carbamazepine (Tegretol). Journal of Neurology Neurosurgery and Psychiatry 1970; 33: 528–531
   PubMed Web of Science ®Google Scholar
• Ethelberg S. On cataplexy in a case of frontal lobe tumor. Acta Psychiatrica Neurologica 1949; 24: 421–427
   PubMedGoogle Scholar
• Frey J., Darbonne C. Fluoxetine suppresses human cataplexy: a pilot study. Neurology 1994; 44: 707–709
   PubMed Web of Science ®Google Scholar
• Gelardi J., Brown J. Hereditary cataplexy. Journal of Neurology Neurosurgery and Psychiatry 1967; 30: 455–457
   PubMed Web of Science ®Google Scholar
• Guilleminault C. Cataplexy. Narcolepsy, C. Guilleminault, W. C. Dement, P. Passauant. Spectrum Publications, Inc, New York 1976; 125–143
   Google Scholar
• Guilleminault C, Wilson R. A., Dement W. C. A study on cataplexy. Archives of Neurology 1974; 31: 255–261
   PubMedGoogle Scholar
• Guilleminault C, Dement W. C., Passouant P. Narcolepsy. Spectrum Publications, New York 1976; 684
   Google Scholar
• Harrison F. Attempt to produce sleep by diencephalic stimulation. Journal of Neurophysiology 1940; 3: 156–165
   Google Scholar
• Isaacson R. L. The limbic system. Plenam, New York 1982; 325
   Google Scholar
• Jouvet M. The role of monoamines and acetylcholine containing in the regulation of the sleep-waking cycle. Ergebnisse der Physiologie 1972; 64: 166–305
   PubMedGoogle Scholar
• Kandt R. S., Emerson R. G., Singer H. S., Valle D. L., Moser H. W. Cataplexy in variant forms of Niemann-Pick disease. Annals of Neurology 1982; 12: 284–288
   PubMed Web of Science ®Google Scholar
• Langdon N., Shindler J., Parkes J. D. Fluoxetine in the treatment of cataplexy. Sleep 1986; 9: 371–373
   PubMed Web of Science ®Google Scholar
• Lascelles R. G., Mohr P. D., Peart I. Unilateral cataplexy associated with systemic lupus erythematosus. Journal of Neurology Neurosurgery and Psychiatry 1976; 39: 1023–1026
   PubMed Web of Science ®Google Scholar
• Lynch H. J., Deng M. H. Pineal responses to stress. Journal of Neural Transmission 1986; 21: 461–473, (suppl)
   Google Scholar
• Mahowald M. W., Schenck C. H. Dissociated states of wakefulness and sleep. Neurology 1992; 42: 44–52, (suppl 6)
   PubMed Web of Science ®Google Scholar
• Matthews W. B. Paroxysmal symptoms in multiple sclerosis. Journal of Neurology Neurosurgery and Psychiatry 1975; 38: 617–623
   PubMed Web of Science ®Google Scholar
• Miley C. E., Foster F. M. Paroxysmal signs and symptoms in multiple sclerosis. Neurology. 1974; 24: 458–461
   PubMed Web of Science ®Google Scholar
• Mitler M. M., Dement W. C. Sleep studies in canine narcolepsy: pattrn and cycle comparisons between affected and normal dogs. Electroencephalography & Clinical Neurophysiology 1977; 43: 691–699
   PubMedGoogle Scholar
• Montplaisir J., Godbout R. Zimelidine: a new treatment for cataplexy. Abstract 4th International Congress of Sleep Research. Bologna, Italy 1983; 332
   Google Scholar
• Montplaisir J., Godbout R. Serotoninergic reuptake mechanisms in the control of cataplexy. Sleep 1986; 9: 280–284
   PubMed Web of Science ®Google Scholar
• Osterman P. O. Short-term and paroxysmal symptoms in multiple sclerosis. Lakartidningen 1977; 12: 1171–1172
   Google Scholar
• Osterman P. O., Westerberg C. E. Paroxysmal attacks in multiple sclerosis. Brain 1975; 98: 189–202
   PubMed Web of Science ®Google Scholar
• Parkes J. D., Fenton G., Struthers G., Curzon G., Kantamaneni B. D., Buxton B. H., Record C. Narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. Quarterly Journal of Medicine 1974; 172: 525–536
   Google Scholar
• Passouant P., Baldy-Molinier M., Aussilloux Ch. Etat de mal cataplectique au cours d'une maladie de Gelineau, influence de la clomipramine. Revue Neurologique 1970; 123: 56–60
   PubMed Web of Science ®Google Scholar
• Pierpaoli W., Maestroni G. J. M. Melatonin: a principal neuroimmunoregulatory and anti-stress hormone: its anti-aging effect. Immunology Letters 1987; 16: 355–362
   PubMed Web of Science ®Google Scholar
• Poirier G., Montplaisir J., Dumont M. Clinical and sleep laboratory study of narcoleptic symptoms in multiple sclerosis. Neurology 1987; 37: 693–695
   PubMed Web of Science ®Google Scholar
• Relkin R. The pineal gland. New England Journal of Medicine 1966; 274: 944–949
   PubMed Web of Science ®Google Scholar
• Romijn H. J. The pineal, a tranquillizing organ. Life Sciences 1978; 23: 2257–2274
   PubMed Web of Science ®Google Scholar
• Rudolph K., Wirz-Justice A., Krauchi K., Feer H. Static magnetic fields decrease nocturnal pineal cAMP in the rat. Brain Research 1988; 446: 159–160
   PubMed Web of Science ®Google Scholar
• Ruzsas C. Functional relationships between pineal gland and habenular complex. Fundamentals and clinics in pineal research, G. P. Trentini, C. De Gaetani, P. Pevet. Raven Press, New York 1987; 257–270
   Google Scholar
• Sandyk R. Successful treatment of multiple sclerosis with magnetic fields. International Journal of Neuroscience 1992; 66: 237–250
   PubMed Web of Science ®Google Scholar
• Sandyk R. Demyelination as an epiphenomenon in multiple sclerosis. International Journal of Neuroscience 1993; 72: 141–148
   PubMedGoogle Scholar
• Sandyk R. Rapid normalization of visual evoked potentials by picotesla range magnetic fields in chronic progressive multiple sclerosis. International Journal of Neuroscience 1994; 77: 243–259
   PubMed Web of Science ®Google Scholar
• Sandyk R. Chronic relapsing multiple sclerosis: a case of rapid recovery by application of weak electromagnetic fields. International Journal of Neuroscience 1995; 82: 223–242
   PubMed Web of Science ®Google Scholar
• Sandyk R. Long term beneficial effects of weak electromagnetic fields in multiple sclerosis. International Journal of Neuroscience, (in press a)
   Web of Science ®Google Scholar
• Sandyk R. The pineal gland, cataplexy, and multiple sclerosis. International Journal of Neuroscience, (in press b)
   Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal plasma melatonin and alpha-melanocyte stimulating hormone levels during exacerbation of multiple sclerosis. International Journal of Neuroscience 1992; 67: 173–186
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in multiple sclerosis patients with affective disorders. International Journal of Neuroscience 1993a; 68: 227–240
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Nocturnal melatonin secretion in suicidal patients with multiple sclerosis. International Journal of Neuroscience 1993b; 71: 173–182
   PubMed Web of Science ®Google Scholar
• Sandyk R., Derpapas K. Magnetic fields normalize visual and brainstem auditory evoked potentials in multiple sclerosis. International Journal of Neuroscience 1993a; 68: 241–253
   PubMedGoogle Scholar
• Sandyk R., Derpapas K. Successful treatment of an acute exacerbation of multiple sclerosis by external magnetic fields. International Journal of Neuroscience 1993b; 70: 97–105
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Resolution of longstanding symptoms of multiple sclerosis by application of picotesla range magnetic fields. International Journal of Neuroscience 1993; 70: 255–269
   PubMed Web of Science ®Google Scholar
• Sandyk R., Awerbuch G. I. Relationship of nocturnal melatonin levels to duration and course of multiple sclerosis. International Journal of Neuroscience 1994; 75: 229–237
   PubMedGoogle Scholar
• Sandyk R., Iacono R. P. Improvement by picotesla magnetic fields of perceptual-motor performance in a patient with chronic progressive multiple sclerosis. International Journal of Neuroscience 1994; 78: 53–66
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Weak electromagnetic fields attenuate tremor in multiple sclerosis. International Journal of Neuroscience 1994; 79: 199–212
   PubMed Web of Science ®Google Scholar
• Sandyk R., Dann L. C. Resolution of Lhermitte's sign in multiple sclerosis by treatment with weak electromagnetic fields. International Journal of Neuroscience 1995; 81: 215–224
   PubMed Web of Science ®Google Scholar
• Schrader H., Goltlibsen O. B., Skomedal G. N. Multiple sclerosis and narcolepsy/cataplexy in a monozygotic twin. Neurology 1980; 30: 105–108
   PubMed Web of Science ®Google Scholar
• Scrima L. An etiology of narcolepsy-cataplexy and a proposed cataplexy neuromechanism. International Journal of Neuroscience 1981; 15: 69–86
   PubMed Web of Science ®Google Scholar
• Semm P. Neurobiological investigations on the magnetic sensitivity of the pineal gland in rodents and pigeons. Comparative Biochemistry and Physiology 1983; 76A: 683–689
   Web of Science ®Google Scholar
• Semm P. Pineal function in mammals and birds is altered by earth-strength magnetic fields. Electromagnetic fields and circadian rhythmicity, M. C. Moore-Ede, S. S. Campbell, R. J. Reiter. Birkhauser, Boston 1992; 53–62
   Google Scholar
• Semm P., Schneider T., Vollrath L. Effects of an earth-strengh magnetic field on electrical activity of pineal cells. Nature 1980; 288: 607–608
   PubMed Web of Science ®Google Scholar
• Shapiro W. R. Treatment of cataplexy with clomipramine. Archives of Neurology 1975; 32: 653–656
   PubMedGoogle Scholar
• Sheremata W. A., Rosenthal D. I., Siddharthan R., Sazant A., Berger J. R. Paroxysmal falling: an unrecognized sign in multiple sclerosis. Annals of Neurology 1985; 18: 130
   Web of Science ®Google Scholar
• Shibasaki H., Kuroiwa Y. Painful tonic seizure in multiple sclerosis. Archives of Neurology 1974; 30: 47–51
   PubMedGoogle Scholar
• Smale L., Cassone V. M., Moore R. Y., Mortin L. P. Paraventricular nucleus projections mediating pineal melatonin and gonadal responses to photoperiod in the hamster. Brain Research Bulletin 1989; 22: 263–269
   PubMed Web of Science ®Google Scholar
• Smith P. Cataplexy in association with meningeomas. Acta Neurologica Scandinavica 1983; 94: 45–47, (suppl)
   Google Scholar
• Sonninen V., Riekkinen P., Rinne U. K. Acid monoamine metabolites in cerebrospinal fluid in multiple sclerosis. Neurology 1973; 23: 760–763
   PubMed Web of Science ®Google Scholar
• Stahl S. M., Layzer R. B., Aminoff M. J., Townsend J. J., Feldon S. Continuous cataplexy in a patient with a midbrain tumor: the limp man syndrome. Neurology 1980; 30: 1115–1118
   PubMed Web of Science ®Google Scholar
• Vizioli R. Les bases neurophysiologiques de la cataplexie. Electroencephalography & Clinical Neurophysiology 1964; 16: 191–193
   PubMedGoogle Scholar
• Walter W. G., Griffiths G. M., Nevin S. Electroencephalogram in case of pathological sleep due to hypothalamic tumor. British Medical Journal 1939; 1: 107–109
   PubMedGoogle Scholar
• Welker H. A., Semm P., Willig R. P., Commentz J. C, Wiltschko W., Vollrath L. Effects of an artificial magnetic field on serotonin N-acetyltransferase activity and melatonin content of the rat pineal gland. Experimental Brain Research 1983; 50: 426–432
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Chess E. K., Anderson L. E. 60-Hz electric-field effects on pineal melatonin rhythms: time course for onset and recovery. Bioelectromagnetics 1986; 7: 239–242
   PubMed Web of Science ®Google Scholar
• Wilson B. W., Stevens R. G., Anderson L. E. Neuroendocrine mediated effects of electromagnetic field exposure: possible role of the pineal gland. Life Sciences 1989; 45: 1319–1332
   PubMed Web of Science ®Google Scholar
• Yanowski J., Witcher J., Adler N., Markey S. P., Klein D. C. Stimulation of the paraventricular nucleus area of the hypothalamus elevates urinary 6-hydroxymelatonin during daytime. Brain Research Bulletin 1987; 19: 129–133
   PubMed Web of Science ®Google Scholar
• Younger D. S., Pedley T. A., Thorpy M. J. Multiple sclerosis and narcolepsy: possible similar genetic susceptibility. Neurology 1991; 41: 447–448
   PubMed Web of Science ®Google Scholar
• Zellweger H. Narcolepsie and epilepsie. Helvetia Paediatrica Acta 1956; 11: 269–274
   PubMedGoogle Scholar
• Zimmerman H. M., Netsky M. G. The pathology of multiple sclerosis. Research Publications of the Association for Research in Nervous and Mental Disorders 1950; 28: 271–312
   PubMedGoogle Scholar